Shire Share Price (SHP)

4,393.75 -89.75 (-2.00%) delayed: 10:34AM GMT
Bid price 4,393.00 Open price 4,451.00
Ask price 4,394.50 Prev close 4,393.00
High price 4,473.50 Spread 0.03%
Low price 4,393.00 Volume 2,417,021

Register now for FREE live Shire share prices, Shire stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Shire Level 2 Data, indepth research tools and investor commentary for Shire (SHP) and other London Stock Exchange equities.

Shire Share Price Chart

Advanced Charts >>

Register now for FREE Shire share price charts

Shire Share Price Information

Name Shire Epic SHP
Sector Pharmaceuticals & Biotechnology ISIN JE00B2QKY057
Activites Shire Pharmaceuticals Group plc (Shire) is a global specialty pharmaceutical company with a strategic focus on meeting the needs of the specialist physician and currently focuses on developing and marketing products in the areas of central nervous system (CNS), gastrointestinal (GI), renal diseases and human genetics. Shire has operations in the world's key pharmaceutical markets (US, Canada, UK, France, Italy, Spain and Germany) as well as a specialist drug delivery unit in the US. Index FTSE 100

Shire Key Numbers

Latest Share Price (p) 4,393.75 Net Gearing (%) 40.01
Market Capitalisation (£m) 40,539.90 Gross Gearing (%) 40.82
Shares in issue (m) 904.20 Debt Ratio 23.83
P/E Ratio 20.32 Debt-to-Equity Ratio 0.45
Total dividends per share (p) 18.01 Assets / Equity Ratio 1.69
Dividend Yield (%) 0.27 Price to book value 4.12
Dividend cover (x) 12.06 ROCE (%) 10.74
Earning per share (p) 220.70 EPS Growth (%) -61.98
52 week high / low 5,509.50 / 3,423.00 DPS Growth (%) 22.10

Shire Director Deals

Dec.Date Type Director Pos No. of Shares
30/06/2016 BUY Bill Burns NED 190
30/06/2016 BUY Anne Minto NED 179
30/06/2016 BUY Dominic Blakemore NED 150
30/06/2016 BUY Olivier Bohoun NED 134
31/03/2016 LOF David Kappler RES 166

More Shire Director Deals >>

Shire Company News

12:00 16/01/2017

Director/PDMR Shareholding

Director/PDMR Shareholding January 16, 2017 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with...

11:00 06/01/2017

Director Declaration

Director Declaration January 6, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that Ian Clark, Non-Executive Director of the Company, was appointed to the Board of Directors of Kite Pharma, Inc. on January 5, 2017. This notification is to satisfy the Company’s...

15:00 04/01/2017

Director Declaration

Director Declaration January 4, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that Ian Clark, Non-Executive Director of the Company, was appointed to the Boards of Directors of Agios Pharmaceuticals, Inc. and Corvus Pharmaceuticals, Inc. on January 3, 2017. This...

More Shire Company News >>

Register now for FREE Shire company news

Shire Share Price Discussions

5 months ago

class pharma company - slipped under the radar (SHP)

why on earth has this exciting pharma company been ignored her for the last 3.5 years? ...... lots has happened in that time, generally for the better on the longer view ..... from a purely chart point of view, the 200 mda is rising quite steadily, with sp recovering well after a sharp fall, and...

more than 1 year ago

class pharma company - slipped under the radar (SHP)

why on earth has this exciting pharma company been ignored her for the last 3.5 years? ...... lots has happened in that time, generally for the better on the longer view ..... from a purely chart point of view, the 200 mda is rising quite steadily, with sp recovering well after a sharp fall, and...

more than 1 year ago

Shire in drug refusal rumours (shp)

There is no smoke without fire, and keen eyed observers will note that Shire Pharmaceutical s is down 7.7% this morning at 372p, having been 13% down at one point. The word in the market is that its application to the US FDA for approval of its Adderall XR treatment for Attention Deficit...

Register now for FREE Shire share price discussions